Krishna Institute of Medical Sciences Q2 FY27: revenue up 39.9% to ₹1,344 Cr, net profit up 3.6% to ₹75 Cr
Results · Finvezto · 4 Nov 2026 · Krishna Institute of Medical Sciences (KIMS)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 1,344 | +14.0% | +39.9% |
| Operating profit | 260 | +16.5% | +27.6% |
| Net profit | 75 | +99.5% | +3.6% |
| Operating margin | 19.4% | +0.4 pp | -1.9 pp |
| Net margin | 5.5% | +2.4 pp | -1.9 pp |
Key points
- Krishna Institute of Medical Sciences Limited reported consolidated revenue from operations of Rs 1,344.40 crore, reported EBITDA of Rs 278.90 crore, and net profit of Rs 76 crore for Q2 FY27, compared to Rs 960.70 crore, Rs 208.20 crore, and Rs 72 crore in Q2 FY26. NSE filing
- Growth was supported by inpatient volumes rising 27.0% year-on-year to 81,668 and average revenue per occupied bed increasing 14.9% to Rs 48,277. NSE filing
- Revenue was ₹1,344 Cr, up 39.9% on a year earlier and up 14.0% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 19.9%, 19.2%, 18.9%, 19.4%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 52, 33, 37, 75.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.